Epithelial-mesenchymal transition in lung development and disease: Does it exist and is it important?

Thorax

Volumn 69, Issue 8, 2014, Pages 760-765

  Bartis, Domokos ^a   Mise, Nikica ^b   Mahida, Rahul Y ^a   Eickelberg, Oliver ^b   Thickett, David R ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BETA CATENIN; BONE MORPHOGENETIC PROTEIN; CALVASCULIN; CLAUDIN; COLLAGEN TYPE 1; CYTOKERATIN; FIBRONECTIN; LYMPHOID ENHANCER FACTOR; NERVE CELL ADHESION MOLECULE; OCCLUDIN; PROTEIN ZO1; SCLEROPROTEIN; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR ZEB1; TRANSCRIPTION FACTOR ZEB2; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UVOMORULIN;

AIRWAY REMODELING; ASTHMA; BRONCHIOLITIS OBLITERANS; CELL ADHESION; CELL COMPONENT; CELL JUNCTION; CELL MOTILITY; CHILDHOOD DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOSKELETON; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; FIBROSING ALVEOLITIS; HUMAN; LUNG ALVEOLUS EPITHELIUM; LUNG CANCER; LUNG DEVELOPMENT; LUNG DISEASE; LUNG DYSPLASIA; LUNG PARENCHYMA; NONHUMAN; PATHOPHYSIOLOGY; PEDIATRICS; PRIORITY JOURNAL; REVIEW; TRANSCRIPTION REGULATION;

EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; LUNG; LUNG DISEASES; TRANSCRIPTION FACTORS;

EID: 84903994596     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2013-204608     Document Type: Review

References (90)

1. Xiao DK, He JX. Epithelial mesenchymal transition and lung cancer. J Thorac Dis 2010;2:154-9.
2. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009;119:1420.
3. Königshoff M, Balsara N, Pfaff E-M, et al. Functional Wnt signaling is increased in idiopathic pulmonary fibrosis. PLoS ONE 2008;3:e2142.
4. Pongracz JE, Stockley RA. Wnt signalling in lung development and diseases. Respir Res 2006;7:15.
5. Zeisberg M, Neilson EG. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 2009;119:1429-37.
6. Kimura K, Endo Y, Yonemura Y, et al. Clinical significance of S100A4 and E-cadherin-related adhesion molecules in non-small cell lung cancer. Int J Oncol 2000;16:1125-31.
7. Günther A, Korfei M, Mahavadi P, et al. Unravelling the progressive pathophysiology of idiopathic pulmonary fibrosis. Eur Respir Rev 2012;21:152-60.
8. Kim KK, Wei Y, Szekeres C, et al. Epithelial cell α3β1 integrin links β-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis. J Clin Invest 2009;119:213-24.
9. Kim KK, Kugler MC, Wolters PJ, et al. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci USA 2006;103:13180-5. (Pubitemid 44338936)
10. Vaughan A, Chapman HA. Regenerative activity of the lung after epithelial injury. Biochim Biophys Acta 2013;1832:922-30.
11. Savagner P, Kusewitt DF, Carver EA, et al. Developmental transcription factor slug is required for effective re-epithelialization by adult keratinocytes. J Cell Physiol 2005;202:858-66. (Pubitemid 40175863)
12. Leopold PL, Vincent J, Wang H. A comparison of epithelial- To-mesenchymal transition and re-epithelialization. Semin Cancer Biol 2012;22:471-83.
13. Brandner JM, Kief S, Grund C, et al. Organization and formation of the tight junction system in human epidermis and cultured keratinocytes. Eur J Cell Biol 2002;81:253-63. (Pubitemid 34568206)
14. Hackett T-L, Warner SM, Stefanowicz D, et al. Induction of epithelial-mesenchymal transition in primary airway epithelial cells from patients with asthma by transforming growth factor-β1. Am J Respir Crit Care Med 2009;180:122-33.
15. Hodge S, Holmes M, Banerjee B, et al. Posttransplant bronchiolitis obliterans syndrome is associated with bronchial epithelial to mesenchymal transition. Am J Transplant 2009;9:727-33.
16. Borthwick LA, Parker SM, Brougham KA, et al. Epithelial to mesenchymal transition (EMT) and airway remodelling after human lung transplantation. Thorax 2009;64:770-7.
17. Holgate ST, Davies DE, Lackie PM, et al. Epithelial-mesenchymal interactions in the pathogenesis of asthma. J Allergy Clin Immunol 2000;105:193-204. (Pubitemid 30109029)
18. Sohal S, Reid D, Soltani A, et al. Evaluation of epithelial mesenchymal transition in patients with chronic obstructive pulmonary disease. Respir Res 2011;12:130.
19. El-Gamel A, Sim E, Hasleton P, et al. Transforming growth factor beta (TGF-β) and obliterative bronchiolitis following pulmonary transplantation. J Heart Lung Transpl 1999;18:828-37. (Pubitemid 29469442)
20. Sohal SS, Reid D, Soltani A, et al. Reticular basement membrane fragmentation and potential epithelial mesenchymal transition is exaggerated in the airways of smokers with chronic obstructive pulmonary disease. Respirology 2010;15:930-8.
21. Jayachandran A, Königshoff M, Yu H, et al. SNAI transcription factors mediate epithelial-mesenchymal transition in lung fibrosis. Thorax 2009;64:1053-61.
22. Parent AE, Choi C, Caudy K, et al. The developmental transcription factor slug is widely expressed in tissues of adult mice. J Histochem Citochem 2004;52: 959-65. (Pubitemid 38857160)
23. Shih J-Y, Yang P-C. The EMT regulator slug and lung carcinogenesis. Carcinogenesis 2011;32:1299-304.
24. Faulkner JL, Szcykalski LM, Springer F, et al. Origin of interstitial fibroblasts in an accelerated model of angiotensin II-induced renal fibrosis. Am J Pathol 2005;167:1193-205. (Pubitemid 41541407)
25. Giampieri S, Manning C, Hooper S, et al. Localized and reversible TGF[beta] signalling switches breast cancer cells from cohesive to single cell motility. Nat Cell Biol 2009;11:1287-96.
26. Tanjore H, Xu XC, Polosukhin VV, et al. Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis. Am J Respir Crit Care Med 2009;180:657-65.
27. Degryse AL, Tanjore H, Xu XC, et al. Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2010;299:L442-L52.
28. Johnson JR, Roos A, Berg T, et al. Chronic respiratory aeroallergen exposure in mice induces epithelial-mesenchymal transition in the large airways. PLoS One 2011;6: e16175.
29. Rock JR, Barkauskas CE, Cronce MJ, et al. Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition. Proc Natl Acad Sci USA 2011;108:E1475-E1483.
30. Perl A-K, Tichelaar J, Whitsett J. Conditional gene expression in the respiratory epithelium of the mouse. Transgenic Res 2002;11:21-9. (Pubitemid 34152360)
31. Hoyles RK, Derrett-Smith EC, Khan K, et al. An essential role for resident fibroblasts in experimental lung fibrosis is defined by lineage-specific deletion of high- Affinity type II transforming growth factor β receptor. Am J Respir Crit Care Med 2011;183:249-61.
32. Yamada M, Kuwano K, Maeyama T, et al. Dual-immunohistochemistry provides little evidence for epithelial-mesenchymal transition in pulmonary fibrosis. Histochem Cell Biol 2008;129:453-62.
33. Quaggin SE, Kapus A. Scar wars: mapping the fate of epithelial- mesenchymal- myofibroblast transition. Kidney Int 2011;80:41-50.
34. LeBleu VS, Taduri G, O'Connell J, et al. Origin and function of myofibroblasts in kidney fibrosis. Nat Med 2013;19:1047-53.
35. Iwaisako K, Brenner DA, Kisseleva T. What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis. J Gastroenterol Hepatol 2012;27:65-8.
36. Thiery JP, Acloque H, Huang RYJ, et al. Epithelial-mesenchymal transitions in development and disease. Cell 2009;139:871-90.
37. Solnica-Krezel L. Conserved patterns of cell movements during vertebrate gastrulation. Curr Biol 2005;15:R213-R228. (Pubitemid 40413386)
38. Rorth P. Collective cell migration. Annu Rev Cell Dev Biol 2009;25:407-29.
39. Andrew DJ, Ewald AJ. Morphogenesis of epithelial tubes: insights into tube formation, elongation, and elaboration. Dev Biol 2010;341:34-55.
40. Morrisey EE, Hogan BL. Preparing for the first breath: genetic and cellular mechanisms in lung development. Dev Cell 2010;18:8-23.
41. Deng C, Wang J, Zou Y, et al. Characterization of fibroblasts recruited from bone marrow-derived precursor in neonatal bronchopulmonary dysplasia mice. J Appl Physiol 2011;111:285-94.
42. Noseda M, Fu Y, Niessen K, et al. Smooth muscle alpha- Actin is a direct target of Notch/CSL. Circ Res 2006;98:1468-70. (Pubitemid 44297068)
43. Noseda M, McLean G, Niessen K, et al. Notch activation results in phenotypic and functional changes consistent with endothelial- To-mesenchymal transformation. Circ Res 2004;94:910-17. (Pubitemid 38490068)
44. Morimoto M, Liu Z, Cheng HT, et al. Canonical Notch signaling in the developing lung is required for determination of arterial smooth muscle cells and selection of Clara versus ciliated cell fate. J Cell Sci 2010;123(Pt 2):213-24.
45. Que J, Wilm B, Hasegawa H, et al. Mesothelium contributes to vascular smooth muscle and mesenchyme during lung development. Proc Natl Acad Sci USA 2008;105:16626-30.
46. Hackett T-L, de Bruin HG, Shaheen F, et al. Caveolin-1 controls airway epithelial barrier function. Implications for Asthma. Am J Resp Cell Mol Biol 2013;49:662-71.
47. Heijink IH, Postma DS, Noordhoek JA, et al. House dust mite-promoted epithelial- To-mesenchymal transition in human bronchial epithelium. Am J Resp Cell Mol Biol 2010;42:69-79.
48. Nihlberg K, Andersson-Sjöland A, Tufvesson E, et al. Altered matrix production in the distal airways of individuals with asthma. Thorax 2010;65:670-6.
49. Sheppard D. Transforming growth factor β: A central modulator of pulmonary and airway inflammation and fibrosis. Proc Am Thorac Soc 2006;3:413-17. (Pubitemid 44033355)
50. Ward C, Forrest IA, Murphy DM, et al. Phenotype of airway epithelial cells suggests epithelial to mesenchymal cell transition in clinically stable lung transplant recipients. Thorax 2005;60:865-71. (Pubitemid 41475217)
51. Borthwick LA, Sunny SS, Oliphant V, et al. Pseudomonas aeruginosa accentuates epithelial- To-mesenchymal transition in the airway. Eur Respir J 2011;37:1237-47.
52. Zhou G, Dada LA, Wu M, et al. Hypoxia-induced alveolar epithelial-mesenchymal transition requires mitochondrial ROS and hypoxia-inducible factor 1. Am J Physiol Lung Cell Mol Physiol 2009;297:L1120-L30.
53. Jiang X, Khan MA, Tian W, et al. Adenovirus-mediated HIF-1α gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection. J Clin Invest 2011;121:2336-49.
54. Felton VM, Inge LJ, Willis BC, et al. Immunosuppression-induced bronchial epithelial-mesenchymal transition: A potential contributor to obliterative bronchiolitis. J Thorac Cardiovasc Surg 2011;141:523-30.
55. Hodgson DB, Saini G, Bolton CE, et al. Thorax in focus: chronic obstructive pulmonary disease. Thorax 2012;67:171-6.
56. Young RP, Whittington CF, Hopkins RJ, et al. Chromosome 4q31 locus in COPD is also associated with lung cancer. Eur Respir J 2010;36:1375-82.
57. Zou W, Zou Y, Zhao Z, et al. Nicotine-induced epithelial-mesenchymal transition via Wnt/β-catenin signaling in human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 2013;304:199-209.
58. Wang Q, Wang Y, Zhang Y, et al. The role of uPAR in epithelial- mesenchymal transition in small airway epithelium of patients with chronic obstructive pulmonary disease. Respir Res 2013;14:67.
59. Churg A, Tai H, Coulthard T, et al. Cigarette smoke drives small airway remodeling by induction of growth factors in the airway wall. Am J Respir Crit Care Med 2006;174:1327-34. (Pubitemid 44913034)
60. Yang L, Lin C, Liu Z-R. P68 RNA helicase mediates PDGF-induced epithelial mesenchymal transition by displacing Axin from β-catenin. Cell 2006;127:139-55. (Pubitemid 44466634)
61. Secker GA, Shortt AJ, Sampson E, et al. TGFβ stimulated re-epithelialisation is regulated by CTGF and Ras/MEK/ERK signalling. Exp Cell Res 2008;314:131-42. (Pubitemid 350180781)
62. Kalluri R. EMT: when epithelial cells decide to become mesenchymal-like cells. J Clin Invest 2009;119:1417-9.
63. Acloque H, Adams MS, Fishwick K, et al. Epithelial-mesenchymal transitions: The importance of changing cell state in development and disease. J Clin Invest 2009;119:1438-49.
64. Milara J, Peiró T, Serrano A, et al. Epithelial to mesenchymal transition is increased in patients with COPD and induced by cigarette smoke. Thorax 2013;68:410-20.
65. Moeller A, Ask K, Warburton D, et al. The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol 2008;40:362-82. (Pubitemid 351249887)
66. Morbini P, Inghilleri S, Campo I, et al. Incomplete expression of epithelial- mesenchymal transition markers in idiopathic pulmonary fibrosis. Pathol Res Pract 2011;207:559-67.
67. Harada T, Nabeshima K, Hamasaki M, et al. Epithelial-mesenchymal transition in human lungs with usual interstitial pneumonia: quantitative immunohistochemistry. Pathol Int 2010;60:14-21.
68. Chilosi M, Zamo A, Doglioni C, et al. Migratory marker expression in fibroblast foci of idiopathic pulmonary fibrosis. Respir Res 2006;7:95.
69. Xiao D, He J. Epithelial mesenchymal transition and lung cancer. J Thorac Dis 2010;2:154.
70. Craene BD, Berx G. Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer 2013;13:97-110.
71. Byers LA, Diao L, Wang J, et al. An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance. Clin Cancer Res 2013;19:279-90.
72. Krebs MG, Sloane R, Priest L, et al. Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. J Clin Oncol 2011;29:1556-63.
73. Hofman V, Bonnetaud C, Ilie MI, et al. Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker. Clin Cancer Res 2011;17:827-35.
74. Chapman HA. Epithelial-mesenchymal interactions in pulmonary fibrosis. Annu Rev Physiol 2011;73:413-35.
75. Adamali HI, Maher TM. Current and novel drug therapies for idiopathic pulmonary fibrosis. Drug Des Dev Ther 2012;6:261.
76. Budd DC, Holmes AM. Targeting TGFβ superfamily ligand accessory proteins as novel therapeutics for chronic lung disorders. Pharm Ther 2012;135:279-91.
77. Guntur VP, Reinero CR. The potential use of tyrosine kinase inhibitors in severe asthma. Curr Opin Allergy Clin Immunol 2012;12:68-75.
78. Akhmetshina A, Palumbo K, Dees C, et al. Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis. Nat Commun 2012;3:735.
79. Nakanishi H, Sugiura T, Streisand JB, et al. TGF-β-neutralizing antibodies improve pulmonary alveologenesis and vasculogenesis in the injured newborn lung. Am J Physiol Lung Cell Mol Physiol 2007;293:L151-L61.
80. McMillan SJ, Xanthou G, Lloyd CM. Manipulation of allergen-induced airway remodeling by treatment with anti- TGF-β antibody: effect on the Smad signaling pathway. J Immunol 2005;174:5774-80. (Pubitemid 40593221)
81. Denton CP, Merkel PA, Furst DE, et al. Recombinant human anti- Transforming growth factor β1 antibody therapy in systemic sclerosis: A multicenter, randomized, placebo-controlled phase I/II trial of CAT-192. Arthritis Rheum 2007;56:323-33. (Pubitemid 46106206)
82. Raghu G, Thickett DR. Pirfenidone for IPF: pro/con debate; the con viewpoint. Thorax 2013;68:605-8.
83. Kumawat K, Menzen MH, Bos IST, et al. Noncanonical WNT-5A signaling regulates TGF-β-induced extracellular matrix production by airway smooth muscle cells. FASEB J 2013;27:1631-43.
84. Heijink IH, de Bruin HG, van den Berge M, et al. Role of aberrant WNT signalling in the airway epithelial response to cigarette smoke in chronic obstructive pulmonary disease. Thorax 2013;68:709-16.
85. Bartis D, Csongei V, Weich A, et al. Down-regulation of canonical and up-regulation of non-canonical Wnt signalling in the carcinogenic process of squamous cell lung. PLoS ONE 2013;8(3):e57393.
86. Kim TH, Kim S-H, Seo J-Y, et al. Blockade of the Wnt/β-catenin pathway attenuates bleomycin-induced pulmonary fibrosis. Tohoku J Exp Med 2011;223:45-54.
87. Henderson WR, Chi EY, Ye X, et al. Inhibition of Wnt/β-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis. Proc Natl Acad Sci USA 2010;107:14309-14.
88. Tennis M, Van Scoyk M, Heasley LE, et al. Prostacyclin inhibits non small cell lung cancer growth by a frizzled 9 dependent pathway that is blocked by secreted frizzled related protein 1. Neoplasia 2010;12:244-53.
89. Bastid J. EMT in carcinoma progression and dissemination: Facts, unanswered questions, and clinical considerations. Cancer Metastasis Rev 2012;31:277-83.
90. Fernandez IE, Eickelberg O. The impact of TGF-β on lung fibrosis: from targeting to biomarkers. Proc Am Thorac Soc 2012;9:111-16.